Caplight Directory>Companies>Antidote-preview>Antidote-1


Antidote

Antidote

Private
LondonHealthcare & Life Scienceshttps://antidote.com

Last Round

Seed

Jan 21, 2026

Total Funding Raised

$57M

Company Overview

Antidote is a legal tech company that provides an AI-powered billing compliance platform designed for law firms to automate time entry compliance, reduce revenue leakage, and streamline billing operations.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

clinical trial recruitmentpatient recruitmentclinical trial matchingpatient engagementhealth techprecision recruitmentclinical trial searchdigital healthCROcontract research organizationpatient advocacy networkbiopharma servicesvalidated patient referrals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antidote Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Antidote Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJan 21, 2026
Growth EquityJun 3, 2021
Series BSep 7, 2017
Series BFeb 5, 2015
Series AMay 8, 2013
Seed
Oct 27, 2011
View all Funding Rounds

Antidote Investors

Notable investors and investment history

InvestorRounds
Amadeus Capital PartnersSeries B, Series A, Seed
Merck Global Health Innovation FundGrowth Equity, Series B
LakestarSeed
Smedvig CapitalSeries B, Growth Equity
The LegalTech FundSeed
LBO FranceGrowth Equity
Octopus InvestmentsSeries B, Series A
View all Investors

Antidote Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Antidote Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antidote's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Year Founded2024
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.